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Review Article
Tumors of the conjunctiva and cornea
Carol L Shields, Jerry A Shields
Tumors of the conjunctiva and cornea comprise a large and varied spectrum of conditions. These tumors
are grouped into two major categories of congenital and acquired lesions. The acquired lesions are further
subdivided based on origin of the mass into surface epithelial, melanocytic, vascular, fibrous, neural,
histiocytic, myxoid, myogenic, lipomatous, lymphoid, leukemic, metastatic and secondary tumors.
Melanocytic lesions include nevus, racial melanosis, primary acquired melanosis, melanoma, and other
ocular surface conditions like ocular melanocytosis and secondary pigmentary deposition. The most
frequent nonmelanocytic neoplastic lesions include squamous cell carcinoma and lymphoma, both of which
have typical features appreciated on clinical examination. The caruncle displays a slightly different array
of tumors compared to those elsewhere on the conjunctiva, as nevus and papilloma are most common, but
oncocytoma and sebaceous gland hyperplasia, adenoma, and carcinoma can be found. In this report, we
provide clinical description and illustration of the many conjunctival and corneal tumors and we discuss
tumor management.
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General Considerations
Tumors of the conjunctiva and cornea occupy a large spectrum of
conditions ranging from benign lesions such as limbal dermoid
or myxoma to aggressive, life‑threatening malignancies such as
melanoma or Kaposi’s sarcoma.[23,88] The clinical differentiation
of these tumors is based on the patient›s medical background
as well as certain typical clinical features of the tumor. The
recognition and proper management of such tumors requires
an understanding of the anatomy of the conjunctiva and cornea
and knowledge of general principles of tumor management,
both of which are described below. The specific clinical and
histopathologic features as well as the management of each
tumor is discussed, based on the authors› personal experience
with over 1,600 patients with conjunctival tumors during a
30‑year period (Shields CL, submitted for publication). In this
report, we review and illustrate the features of conjunctival
and corneal tumors for the general ophthalmologist as well
as the specialist who might occasionally examine an affected
patient and want a quick reference for recognition and therapy.
Anatomy
The conjunctiva is a continuous mucous membrane that
covers the anterior portion of the globe. It extends from the
eyelid margin onto the back surface of the eyelid (palpebral
portion), into the fornix (forniceal portion), onto the surface
of the globe (bulbar portion), and up to the corneoscleral
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limbus (limbal portion). The conjunctiva is composed of
epithelium and stroma. The epithelium consist of both stratified
squamous and columnar epithelium.[89] The squamous pattern
is found near the limbus and the columnar pattern is found near
the fornix. The stroma is composed of fibrovascular connective
tissue that thickens in the fornix and thins at the limbus.
Special regions of the conjunctiva include the plica
semilunaris and caruncle. The plica semilunaris is a vertically
oriented fold of conjunctiva, located in the medial portion of the
bulbar conjunctiva. It is speculated that the plica semilunaris
represents a remnant of the nictitating membrane found in
certain animals. The caruncle is located in the medial canthus
between the upper and lower punctum. It contains both
conjunctival and cutaneous structures such as nonkeratinized
stratified squamous epithelium overlying the stroma of
fibroblasta, melanocytes, sebaceous glands, hair follicles, and
striated muscle fibers.
Neoplasms can arise in the conjunctiva from both its
epithelial and stromal structures. These are similar clinically
and histopathologically to tumors that arise from other mucous
membranes in the body. However, unlike other mucous
membranes in the body, the conjunctiva is partially exposed
to sunlight, which may be a factor in the development of some
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tumors. Similarly, the cornea can develop epithelial tumors, but
corneal stromal tumors are uncommon. The caruncle, with its
unique composition of both mucous membrane and cutaneous
structures, can generate tumors found both in mucosa and skin.
Diagnostic approaches
Unlike many other mucous membranes in the body, the
conjunctiva is readily visible. Thus, tumors and related lesions
that occur in the conjunctiva are generally recognized at a
relatively early stage. Because many of these tumors have
typical clinical features, an accurate diagnosis can often be made
by external ocular examination and slit‑lamp biomicroscopy,
provided that the clinician is familiar with their clinical
characteristics. A diagnostic biopsy is not usually necessary
in cases of smaller tumors (≤4 clock hours limbal tumor
or ≤15 mm basal dimension) that appear benign. If a smaller
tumor does require a biopsy, it is often better to completely
remove the lesion in one operation (excisional biopsy). In cases
of larger lesions (>4 clock hour limbal tumor or >15 mm basal
dimension), however, it may be appropriate to remove a portion
of the tumor (incisional biopsy) to obtain a histopathologic
diagnosis prior to embarking upon more extensive therapy, as
conjunctival tumors are readily accessible to incisional biopsy.
Occasionally, exfoliative cytology[90] and fine‑needle aspiration
biopsy can provide useful information on the basis of a few cells.
In addition to evaluation of the conjunctival lesion,
meticulous slit‑lamp examination of the cornea is essential
in patients with suspected conjunctival tumors. Invasion of
squamous cell carcinoma and melanoma into the peripheral
cornea may appear as a subtle, gray surface opacity. It is
important to completely outline such corneal involvement prior
to surgery, because it is often less visible through the operating
microscope than it is with slit‑lamp biomicroscopy in the office.
Management
Depending on the presumptive diagnosis and the size and
extent of the lesion, management of a conjunctival tumor
can consist of serial observation, incisional biopsy, excisional
biopsy, cryotherapy, chemotherapy, radiotherapy, modified
enucleation, orbital exenteration or various combinations of
these methods.[1,78,79,80,86] If large areas of conjunctiva are removed,
mucous membrane grafts from the conjunctiva of the opposite
eye, buccal mucosa, or amniotic membrane may be necessary.[42,60]
Observation
Observation is generally the management of choice for most
benign, asymptomatic tumors of the conjunctiva. Selected
examples of lesions that can be observed without interventional
treatment include pingueculum, dermolipoma, and nevus.
External or slit‑lamp photographs are advisable to document
all lesions and are critical to follow‑up of the more suspicious
lesions. Most patients are examined every 6 to 12 months
looking for evidence of growth, malignant change, or secondary
effects on normal surrounding tissues.
Incisional biopsy
Incisional biopsy is reserved for extensive suspicious tumors
that are symptomatic or suspected to be malignant. Examples
include large squamous cell carcinoma, primary acquired
melanosis, melanoma, and conjunctival invasion by sebaceous
gland carcinoma. It should be understood that if tumors occupy
4 clock hours or less on the bulbar conjunctiva, excisional
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biopsy is generally preferable to incisional biopsy. However,
larger lesions can be approached by incisional wedge biopsy or
punch biopsy. Definitive therapy would then be planned based
on the results of biopsy. Incisional biopsy is also appropriate
for conditions that are ideally treated with radiotherapy,
chemotherapy, or other topical medications. These lesions
include lymphoid tumors, metastatic tumors, extensive
papillomatosis, and some cases of squamous cell carcinoma and
primary acquired melanosis. Incisional biopsy should generally
be avoided for melanocytic tumors, especially melanoma, as
this can increase the risk for numerous tumor recurrences.[64]
Excisional biopsy
Primary excisional biopsy is appropriate for relatively
smaller tumors (≤4 clock hours limbal tumor or ≤15 mm basal
dimension) that are symptomatic or suspected to be malignant.
In these situations, excisional biopsy is preferred over incisional
biopsy to avoid inadvertent tumor seeding. Examples of benign
and malignant lesions that are ideally managed by excisional
biopsy include symptomatic limbal dermoid, epibulbar osseous
choristoma, steroid‑resistant pyogenic granuloma, squamous
cell carcinoma, and melanoma. When such lesions are located in
the conjunctival fornix they can be completely excised and the
conjunctiva reconstructed primarily with absorbable sutures,
sometimes with fornix deepening sutures or symblepharon ring
to prevent adhesions. If the defect cannot be closed primarily,
then a mucous membrane graft can be inserted.
Most primary malignant tumors of the conjunctiva, like
squamous cell carcinoma and melanoma, arise in the interpalpebral
area near the limbus and the surgical technique for limbal tumors
is different than that for forniceal tumors.[72,78,79] Limbal neoplasms
possibly can invade through the corneal epithelium and sclera
into the anterior chamber and also through the soft tissues into
the orbit. Thus, it is often necessary to remove a thin lamella of
sclera to achieve tumor‑free margins and to decrease the chance
for tumor recurrence. In this regard, we employ a partial lamellar
sclerokeratoconjunctivectomy with primary closure in for such
tumors (Fig. 1). Because cells from these friable tumors can seed
into adjacent tissues, a gentle technique without touching the
tumor (no touch technique) is advised. Additionally, the surgery
should be performed using microscopic technique and the
operative field should be left dry so that cells adhere to the
resected tissue. It is wise to avoid wetting the field with balanced
salt solution until after the tumor is completely removed to
minimize seeding of cells. There are no published comparative
reports of the various surgical techniques for tumor excision,
but discussions at the 1997 International Congress of Ocular
Oncology in Jerusalem supported the above surgical principles.
The technique for resection of limbal tumors is shown
in Fig. 1. Using retrobulbar anesthesia and the operating
microscope, the corneal epithelial component is approached
first and the conjunctival component is dissected second, with
the goal of excising the entire specimen completely in one piece.
Absolute alcohol soaked on an applicator is gently applied to
the entire corneal component. This causes epithelial cellular
devitalization and allows easier release of the tumor cells from
Bowman’s layer. A beaver blade is used to microscopically
outline the malignancy within the corneal epithelium using
a delicate epithelial incision or epitheliorhexis technique
2 mm outside the corneal component. The beaver blade is
then used to sweep gently the affected corneal epithelium
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Figure 1: Surgical excision of conjunctival malignancy using the “no touch” technique. (a) Absolute alcohol is applied by a cotton tip applicator to
the involved cornea to allow for controlled corneal epitheliectomy. (b) The corneal epithelium is scrolled off using a controlled sweeping motion
with a beaver blade. (c) The conjunctival incision is made approximately 4 mm outside the tumor margin. A beaver blade is used to create a thin
lamella of tumor‑free sclera underlying the limbal portion of the tumor. (d) The conjunctival malignancy is removed, along with tumor‑free margins,
including underlying sclera and limbal corneal epithelium. (e) Cryotherapy is applied to the conjunctiva at the site of resection. (f) Closure of the
conjunctiva with absorbable sutures is performed

from the direction of the central cornea to limbus, into a
scroll that rests at the limbus. Next, a pentagonal or circular
conjunctival incision based at the limbus is made 4–6 mm
outside the tumor margin. The incision is carried through the
underlying Tenon’s fascia until the sclera is exposed so that
full thickness conjuctiva and Tenon’s fascia is incorporated into
the excisional biopsy. Cautery is applied to control bleeding.
A second incision is then outlined by a superficial scleral
groove approximately 0.2 mm in depth and 2.0 mm outside
the base of the overlying adherent conjunctival mass. This
groove is continued anteriorly to the limbus. The area outlined
by the scleral groove is removed by flat dissection of 0.2‑mm
thickness within the sclera in an attempt to remove a superficial
lamella of sclera, overlying Tenon’s fascia and conjunctiva
with tumor, and the scrolled corneal epithelium. In this way,
the entire tumor with tumor‑free margins is removed in one
piece without touching the tumor itself (no touch technique).
The removed specimen is then placed flatly on a piece of thin
cardboard from the surgical tray and then placed in fixative
and submitted for histopathologic studies. This step prevents
the specimen from folding and allows better assessment of the
tumor margins histopathologically. The used instruments are
then replaced with fresh instruments for subsequent steps, to
avoid contamination of healthy tissue with possible tumor cells.
After excision of the specimen, cryotherapy is applied to the
margins of the remaining bulbar conjunctiva. This is performed
by freezing the surrounding bulbar conjunctiva as it is lifted
away from the sclera using the cryoprobe. When the ice ball
reaches a size of 4–5 mm, it is allowed to thaw and the cycle
repeated once more. The cryoprobe is then moved to an adjacent
area of the conjunctiva and the cycle is repeated until all of the
margins have been treated by this method. It is not necessary to
treat the corneal margins with cryoapplication. The tumor bed
is treated with absolute alchohol wash on cotton tip applicator
and bipolar cautery, avoiding cryotherapy directly to the sclera.

Using clean instruments, the conjunctiva is mobilized for
closure of the defect by loosening the intermuscular septum
with Steven’s scissor spreading and creation of transpositional
conjunctival flaps. Closure is completed with interrupted
absorbable 6‑0 or 7‑0 sutures. If the surgeon prefers, an area of
bare sclera can be left near the limbus, but we prefer complete
closure as this promotes better healing and allows for facility
of further surgery if the patient should develop recurrence. The
patient is treated with topical antibiotics and corticosteroids
for two weeks and then followed at 3‑ to 6‑month intervals.
Cryotherapy
In the management of conjunctival tumors, cryotherapy can
be used as a supplemental treatment to excisional biopsy
as described above. The advantages of cryotherapy include
elimination of subclinical, microscopic tumor cells and
prevention of recurrence of malignant tumors, including
squamous cell carcinoma and melanoma.[14,64] It can also be used
as a principal treatment for primary acquired melanosis and
pagetoid invasion of sebaceous gland carcinoma. If cryotherapy
can devitalize the malignant or potentially malignant cells in
these instances, radical surgery like orbital exenteration can
often be delayed or avoided. The disadvantages of cryotherapy
include conjunctival chemosis that may last over one week and
if the technique is misused and the globe is accidentally frozen,
cataract, uveitis, scleral, and corneal thinning, and phthisis
bulbi can occur.
Chemotherapy
Recent evidence has revealed that topical eyedrops comprised
of mitomycin C, 5‑fluorouracil, or interferon are effective
in treating epithelial malignancies such as squamous cell
carcinoma, primary acquired melanosis, and pagetoid invasion
of sebaceous gland carcinoma.[19,20,32,38,53,56,57,96,97] Mitomycin C or
5‑fluorouracil are employed most successfully for squamous
cell carcinoma, especially after tumor recurrence following
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previous surgery. This medication is prescribed topically
4 times daily for a 1‑week period followed by a 1‑week hiatus
to allow the ocular surface to recover [Table 1]. This cycle is
repeated once again so that most patients receive a total of two
weeks of the chemotherapy topically. Both mitomycin C and
5‑fluorouracil are most effective for squamous cell carcinoma
and less effective for primary acquired melanosis and pagetoid
invasion of sebaceous gland carcinoma. Caution should be used
with this medication as it is most effective for intraepithelial
disease and much less effective or ineffective for deeper disease.
Toxicities include most commonly dry eye findings, superficial
punctate epitheliopathy, and punctal stenosis. Corneal melt,
scleral melt, and cataract can develop if these agents are used
with open conjunctival wounds or used excessively. Topical
interferon can be effective for squamous epithelial malignancies
and is less toxic to the surface epithelium, but this medication
may require many months of use to effect a result.[32]
Radiotherapy
Two forms of radiotherapy are employed for conjunctival tumors,
namely external beam radiotherapy and custom‑designed
plaque radiotherapy. External beam radiotherapy to a total
dose of 3,000–4,000 cGy is used to treat conjunctival lymphoma
and metastatic carcinoma when they are too large or diffuse
to excise locally. Side effects of dry eye, punctate epithelial
abnormalities, and cataract should be anticipated.
Custom‑designed plaque radiotherapy[65] to a dose of
3,000–4,000 cGy can be used to treat conjunctival lymphoma or
metastasis. A higher dose of 6,000–8,000 cGy can be employed to
treat the more radiation resistant melanoma and squamous cell
carcinoma. In general, plaque radiotherapy is reserved for those
patients who have diffuse tumors that are incompletely resected
and for those who display multiple recurrences. The two designs
for conjunctival custom plaque radiotherapy include a conformer
plaque technique with six fractionated treatment sessions as an
outpatient or a reverse plaque technique with the device sutured
onto the episcleral as an inpatient. In unique instances, plaque
radiotherapy to a low dose of 2,000 cGy is employed for benign
conditions, including steroid resistant pyogenic granuloma that
show recurrence after surgical resection.[26] This treatment should
be performed by experienced radiation oncologists and ocular
oncologists. There is no published report on a comparison of
these radiotherapy techniques.
Modified enucleation
Modified enucleation is a treatment option for primary
malignant tumors of the conjunctiva that have invaded
through the limbal tissues into the globe, producing secondary
Table 1: Protocol for Use of Mitomycin C for Conjunctival
Squamous Cell Neoplasia and Primary Acquired Melanosis
Time

Medication and Frequency

Week 1

Slit‑lamp biomicroscopy
Place upper and lower punctal plugs
Cycle 1: mitomycin C 0.04% qid to the affected eye

Week 2

No medication

Week 3

Cycle 2: mitomycin C 0.04% qid to the affected eye

Week 4

No medication
Slit‑lamp biomicroscopy
Prescribe more cycles if residual tumor exists
Remove punctal plugs after all medication complete

1933

glaucoma. This occurrence is quite rare but can occasionally
be found with squamous cell carcinoma and melanoma.
The uncommon mucoepidermoid variant and spindle cell
variant of squamous cell carcinoma of the conjunctiva has a
greater tendency for intraocular invasion.[2,7,25] At the time of
enucleation, it is necessary to remove the involved conjunctiva
intact with the globe so as to avoid spreading tumor cells.
Thus, the initial peritomy should begin at the limbus, but
when the tumor is approached, the incision should proceed
posteriorly from the limbus to surround the tumor‑affected
tissue by at least 3–4 mm. The tumor will remain adherent to
the globe at the limbus. Occasionally, a suture is employed
through the surrounding conjunctiva into the episclera to
secure the tumor to the globe so that it will not be displaced
during subsequent manipulation. The remaining steps of
enucleation are gently performed and the globe is removed
with tumor adherent after cutting the optic nerve from the
nasal side. The margins of the remaining, presumed unaffected
conjunctiva are treated with double freeze‑thaw cryotherapy.
Often this surgical technique leaves the patient with a limited
amount of residual unaffected conjunctiva for closure. In these
instances, a mucous membrane graft or amniotic membrane
graft may be necessary for adequate closure and to provide
fornices for a prosthesis. In some instances, a simple horizontal
inferior forniceal conjunctival incision from canthus to canthus
may suffice, as long as the conformer is constantly worn as
a template so the new conjunctival fornix grows deep and
around this structure.
Orbital exenteration
Orbital exenteration is probably the treatment of choice for
primary malignant conjunctival tumors that have invaded
the orbit or that exhibit complete involvement of the
conjunctiva.[64,84,86] Either an eyelid‑removing or eyelid‑sparing
exenteration is employed, depending on the extent of eyelid
involvement. The eyelid‑sparing technique is preferred in that
the patients have better cosmetic appearance and heal within
2 or 3 weeks. Specifically, if the anterior lamella of the eyelid
is uninvolved with tumor, an eyelid‑sparing (eyelid‑splitting)
exenteration may be accomplished. [78,84,86] Other options
to exenteration are radiotherapy using the external beam
approach or the brachytherapy approach. There are too few
cases in the literature to do a scientific comparison.
Mucous membrane graft
Mucous membrane grafts are occasionally necessary to replace
vital conjunctival tissue after removal of extensive conjunctival
tumors. The best donor sites include the forniceal conjunctiva of
the ipsilateral or contralateral eye and buccal mucosa from the
posterior aspect of the lower lip or lateral aspect of the mouth.
Such grafts are usually removed by a freehand technique,
fashioned to fit the defect, and secured into place with cardinal
and running absorbable 6‑0 or 7‑0 sutures. Currently, in most
instances, we employ a donor amniotic membrane graft to
replace lost conjunctiva.[42,60] The tissue is delivered frozen and
must be defrosted for 20 minutes. The fine, transparent material
is carefully peeled off its cardboard surface, laid basement
membrane side up, and sutured into place with absorbable
sutures. Topical antibiotic and steroid ointments are applied
following all conjunctival grafting procedures.
It is important that the surgeon use a minimal manipulation
technique for tumor resection. For graft harvest and placement,
we prefer to use clean, sterile instruments at both the donor
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and the recipient sites to avoid transfer and implantation of
tumor cells into previously uninvolved areas.

Congenital Lesions
A variety of tumors and related conditions may be present
at birth or become clinically apparent shortly after birth.[10,74]
Most of the lesions to be considered here are choristomas,
consisting of displaced tissue elements normally not found in
these areas. A simple choristoma is comprised of one tissue
element such as epithelium whereas a complex choristoma
represents variable combinations of ectopic tissues like bone,
cartilage, and lacrimal gland. Despite their presence at a young
age, all of the conjunctival choristomas discussed herein are
sporadic, without hereditary tendency.
Dermoid
Conjunctival dermoid is a congenital well‑circumscribed
yellow‑white solid mass that involves the bulbar conjunctiva
or at the corneoscleral limbus.[10,11,49,72,74] It characteristically
occurs near the limbus inferotemporally and often this
tumor has fine white hairs, best seen with slit lamp
biomicroscopy (Fig. 2). In rare cases, it can extend to the
central cornea or be located in other quadrants on the bulbar
surface. There are three types of dermoids, classified on the
extent of involvement. The first type includes the small limbal
dermoid, straddling the limbus and approximately 5 mm
in diameter. The second type is larger, often involving the
entire surface of the cornea, but not deeper than Descemet›s
membrane. The third type is most extensive and the dermoid
involves the cornea, anterior chamber, and iris stroma and its
posterior aspect is lined by the iris pigment epithelium. The
various types are related to the time during fetal development
in which the dermoid develops, with more severe types
occurring earlier.
Conjunctival dermoid may occur as an isolated lesion
or it can be associated with Goldenhar’s syndrome. Hence,
the patient should be evaluated for ipsilateral or bilateral
preauricular skin appendages, hearing loss, eyelid coloboma,
orbitoconjunctival dermolipoma, and cervical vertebral
anomalies that comprise this nonheritable syndrome.
Histopathologically, the conjunctival dermoid is a simple
choristomatous malformation that consists of dense fibrous
tissue lined by conjunctival epithelium with deeper dermal
elements including hair follicles and sebaceous glands.
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from astigmatism. These can be approached by lamellar
keratosclerectomy with primary closure of overlying tissue
if the defect is superficial or closure using corneal graft if the
defect is deep or full thickness. It has been reported that the
cosmetic appearance may improve, but the refractive and
astigmatic error and visual acuity may not change.[49] When
the lesion involves the central cornea, a lamellar or penetrating
keratoplasty may be necessary and long‑term amblyopia can
be a problem.[72] Occasionally, extensive dermoids involve the
lateral canthus and carefully planned excision with lateral
canthal repair is necessary.
Dermolipoma
Dermolipoma is believed to be congenital and present at birth,
but it typically remains asymptomatic for years and may not
be detected until adulthood when it protrudes from the orbit
through the conjunctival fornix superotemporally (Fig. 3). It
appears as a pale‑yellow, soft, fluctuant, fusiform mass below the
palpebral lobe of the lacrimal gland, best visualized with the eye
in inferonasal gaze. It usually extends for a variable distance into
the orbital fat and onto the bulbar conjunctiva, and occasionally it
can extend anteriorly to reach the limbus. Unlike herniated orbital
fat, dermolipoma can contain fine white hairs on its surface and
it cannot be reduced with digital pressure into the orbit.
With computed tomography (CT) or magnetic resonance
imaging (MRI), dermolipoma has features similar to orbital fat
from which it may be indistinguishable. Histopathologically,
it is lined by conjunctival epithelium on its surface and the
subepithelial tissue has variable quantities of collagenous
connective tissue and adipose tissue. Pilosebaceous units
and lacrimal gland tissue may occasionally be present. The
majority of dermolipomas require no treatment, but larger
symptomatic ones or those that are cosmetically unappealing
can be managed by excision of the entire orbitoconjunctival
lesion through a conjunctival forniceal approach or by simply
removing the anterior portion of the lesion in a manner similar
to that used to remove prolapsed orbital fat.
Epibulbar osseous choristoma
Epibulbar osseous choristoma is a rigid deposit of bone
generally located in the bulbar conjunctiva superotemporally
(Fig. 4).[70] It is believed to be congenital and typically remains
undetected until personally palpated by the patient in the
preteen years. It is clinically suspected due to its rock‑hard

The management of an epibulbar dermoid includes simple
observation if the lesion is small and visually asymptomatic.
It is possible to excise the lesion for cosmetic reasons, but the
remaining corneal scar is sometimes cosmetically unacceptable.
Larger or symptomatic dermoids can produce visual loss

a

b

Figure 2: Epibulbar dermoid. (a) Limbal dermoid. (b) Central corneal
dermoid

Figure 3: Dermolipoma in superotemporal conjunctival fornix
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consistency on palpation, although fibrous tissue tumors
can feel similar. The diagnosis can be confirmed with
ultrasonography or computed tomography to illustrate the
calcium component. This tumor is generally best managed by
periodic observation. Occasionally patients report a foreign
body sensation and symptomatic lesions can be excised with
a circumtumoral conjunctival incision followed by dissection
to bare sclera for full thickness conjunctival resection. For
those tumors that might be adherent to the sclera, a superficial
sclerectomy might be warranted.[70]
Lacrimal gland choristoma
Lacrimal gland choristoma is a congenital lesion, discovered
in young children as an asymptomatic pink stromal mass,
typically in the superotemporal or temporal portion of the
conjunctiva.[45] It is speculated that this lesion represents small
sequestrations of the embryonic evagination of the lacrimal
gland from the conjunctiva. The lacrimal gland choristoma can
masquerade as a focus of inflammation due to its pink color.
Rarely, a cystic appearance ensues from this secretory mass if
there is no connection to the conjunctival surface. Excisional
biopsy is usually performed to confirm the diagnosis.
Respiratory choristoma
In unique instances, a cystic choristoma, appearing as
congenital sclerocorneal ectasia, is found. In one report, this
was found to manifest respiratory mucosa.[98]
Complex choristoma
The conjunctival dermoid and epibulbar osseous choristoma
are termed simple choristomas as they contain one tissue type
such as skin or bone. A complex choristoma contains a greater
variety of tissue like dermal appendages, lacrimal gland tissue,
cartilage, bone, and occasionally other elements. Complex
choristoma contains tissue derived from two germ layers. It is
quite variable in its clinical appearance and may cover much of
the epibulbar surface or it may form a circumferential growth
pattern around the limbus (Fig. 5). For example, a tumor
with extensive lacrimal tissue appears as a lobular pink mass
whereas one with dermal tissue appears yellow and thick
and one with cartilage displays a smooth blue‑gray hue. The
complex choristoma has a peculiar association with the linear
nevus sebaceous of Jadassohn.[58,75,82] The nevus sebaceous of
Jadassohn includes cutaneous features with sebaceous nevus

Figure 4: Epibulbar osseous choristoma on bulbar conjunctiva
superotemporally, presenting as a firm, palpable mass
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in the facial region and neurologic features including seizures,
mental retardation, arachnoid cyst, and cerebral atrophy.
The ophthalmic features of this syndrome include epibulbar
complex choristoma and posterior scleral cartilage.[82]
The management of the complex choristoma depends upon
the extent of the lesion. Observation or wide local excision with
mucous membrane graft reconstruction are options. In the rare
case of a very extensive lesion, where the lesion causes dense
amblyopia with no hope for visual acuity, modified enucleation
with ocular surface reconstruction may be necessary.

Benign Tumors of Surface Epithelium
Several benign tumors and related conditions can arise from
the squamous epithelium of the conjunctiva.
Papilloma
Squamous papilloma is a benign tumor, documented to
be associated with human papillomavirus (subtypes 6, 11,
16, and 18) infection of the conjunctiva. [55,88] This tumor
can occur in both children and adults. It is speculated that
the virus is acquired through transfer from the mother›s
vagina to the newborn›s conjunctiva as the child passes
through the mother›s birth canal. Papilloma appears as a
pink fibrovascular frond of tissue arranged in a sessile or
pedunculated configuration. The numerous fine vascular
channels ramify through the stroma beneath the epithelial
surface of the lesion. In children, the lesion is usually small,
multiple, and located in the inferior fornix (Fig. 6). In adults,
it is usually solitary, more extensive, and can often extend
to cover the entire corneal surface simulating malignant
squamous cell carcinoma. Histopathologically, the lesion
shows numerous vascularized papillary fronds lined by
acanthotic epithelium.
In the case of a small sessile papilloma in a child, there are
several treatment options. Sometimes, periodic observation
allows for slow spontaneous resolution of the viral‑produced
tumor. Larger or more pedunculated lesions are generally
symptomatic with foreign body sensation, chronic mucous
production, hemorrhagic tears, incomplete eyelid closure,
and poor cosmetic appearance. These lesions are unlikely
to show a favorable response to observation or steroids and
are best managed by surgical excision. Complete removal

Figure 5: Epibulbar complex choristoma that was found
histopathologically to have cartilage and ectopic lacrimal gland
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of the mass without direction manipulation of the tumor
(no touch technique) is generally advisable to avoid spreading
of the tumor‑related virus. Double freeze‑thaw cryotherapy is
applied to the remaining conjunctiva around the excised lesion
in order to help prevent tumor recurrence. In some instances,
the pedunculated tumor is frozen alone and allowed to slough
off the conjunctival surface later. For some large unwieldy
pedunculated tumors, complete cryotherapy of the mass down
its stalk to its base is performed and excision while the mass
is in the frozen state is achieved. This is especially important
for large lesions to allow for traction on the tumor without
forcep manipulation. Closure is completed with absorbable
sutures. Topical interferon and mitomycin C have been
employed for conjunctival papillomas.[27,47] For those lesions
that show recurrence, oral cimetidine for several months can
resolve the papilloma virus‑related tumor by boosting the
patient›s immune system and stimulating regression of the
mass (Fig. 6).[55]
Keratoacanthoma
The conjunctiva can give rise to benign reactive inflammatory
lesions that simulate carcinoma including pseudocarcinomatous
hyperplasia and its variant, keratoacanthoma.[39] In some
instances a distinct nodule is found. This lesion appears
gelatinous or leukoplakic, similar to squamous cell carcinoma
of the conjunctiva, but its onset may be more rapid. Massive
acanthosis, hyperkeratosis and parakeratosis is found
histopathologically.[39] Treatment is complete resection as this
may be difficult to differentiate from carcinoma both clinically
and histopathologically.
Hereditary benign intraepithelial dyskeratosis
Hereditary benign intraepithelial dyskeratosis (HBID) is
a peculiar condition seen in an inbred isolate of white,
African‑American, and Native American (Haliwa Indians).
This group resided initially in North Carolina. Hereditary
benign intraepithelial dyskeratosis has subsequently been
detected in several other parts of the United States. It is an
autosomal dominant disorder characterized by bilateral
elevated fleshy plaques on the nasal or temporal perilimbal
conjunctiva (Fig. 7).[63] Similar plaques can occur on the buccal
mucosa. It can remain relative asymptomatic or it can cause
severe redness and foreign body sensation. In some instances
it can extend onto the cornea. It has no known malignant
potential. It is characterized histopathologically by acanthosis,
dyskeratosis on the epithelial surface and deep within the
epithelium, and prominent chronic inflammatory cells.
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lubricants and judicious used of topical corticosteroids. Larger
symptomatic lesions can be managed by local resection with
mucous membrane grafting if necessary.
Epithelial inclusion cyst
Conjunctival cysts can occur spontaneously or following
inflammation, surgery, or nonsurgical trauma.
Histopathologically, they are lined by conjunctival epithelium
and are filled with clear fluid that often contains desquamated
cellular debris (Fig. 8). These cysts can be simply observed or
they can be excised completely with primary closure of the
conjunctiva.
Dacryoadenoma
Dacryoadenoma is a rare conjunctival tumor, noted in
patients as a pink mass. In one report, this tumor was found
in the inferior bulbar region of a 48‑year‑old woman.[30] It is
uncertain if the lesion is congenital or acquired. This benign
tumor appears to originate from the surface epithelium and
proliferate into the stroma, forming glandular lobules similar
to the lacrimal gland.
Keratotic plaque
Keratotic plaque is a white limbal or bulbar conjunctival
mass, usually in the interpalpebral region.[76] It is composed
of acanthosis and parakaratosis with keratinization of the
epithelium. It appears similar to squamous cell carcinoma
with leukoplakia.
Actinic keratosis
Actinic keratosis is a frothy, white lesion usually located
over a chronically inflamed pingueculum or pterygium.[76] It
is also referred to as dysplasia, actinic keratosis variety.
Histopathologically, it is composed of a proliferation of surface
epithelium with keratosis. Clinically, it resembles squamous
cell carcinoma of the conjunctiva.

Malignant Lesions of Surface Epithelium
Squamous cell neoplasia can occur as a localized lesion
confined to the surface epithelium (conjunctival intraepithelial
neoplasia or dysplasia) or as a more invasive squamous cell
carcinoma that has broken through the basement membrane
and invaded the underlying stroma.[2,4,25,29,36,85,92] The former

Hereditary benign intraepithelial dyskeratosis is a benign
condition that does not usually require aggressive treatment.
Smaller, less symptomatic lesions can be treated with ocular

a

b

Figure 6: Recurrent conjunctival papilloma in a child. (a) The
fibrovascular mass caused bloody tears. (b) Following 3 months of
oral cimetidine, the mass resolved

Figure 7: Hereditary benign intraepithelial dyskeratosis in a young
woman who was a descendent of a Haliwa Indian. The opposite eye
had a similar lesion
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has no potential to metastasize but the latter can gain access
to the conjunctival lymphatics and occasionally metastasize to
regional lymph nodes. It has been found that most squamous
cell neoplasia is related to human papillomavirus infection of
the conjunctival epithelium and this is most certain in those
patients with bilateral squamous cell neoplasia and those
immunosuppressed patients who develop this disease.[48]

Histopathologically, mild CIN (dysplasia) is characterized
by a partial thickness replacement of the surface epithelium
by abnormal epithelial cells that lack normal maturation.
Severe CIN (severe dysplasia) is characterized by a nearly
full‑thickness replacement of the epithelium by similar cells.
Carcinoma‑in‑situ represents full thickness replacement by
abnormal epithelial cells.

The currently accepted term for the localized variety
is conjunctival intraepithelial neoplasia (CIN), but others
prefer the terms dysplasia (mild, moderate, or severe) and
carcinoma‑in‑situ. When the abnormal cellular proliferation
involves only partial thickness of the epithelium it is classified
as mild CIN, a condition also called mild or moderate dysplasia.
When it affects full thickness epithelium it is called severe
CIN, a condition also called severe dysplasia. In these cases,
there may be an intact surface layer of cells. Where there are
no longer normal surface cells then the process is termed
carcinoma‑in‑situ. It is stressed that these are histopathologic
terms and the differential between CIN mild and CIN severe
cannot be made clinically.

Squamous cell carcinoma
Squamous cell carcinoma an extension of abnormal epithelial
cells through the basement membrane to gain access to
the conjunctival stroma. Clinically, invasive squamous
cell carcinoma is generally larger and more elevated than
CIN (Fig. 10). Leukoplakia may be variable. Uncommonly,
lesions that are untreated or incompletely excised can invade
through the corneoscleral lamella into the anterior chamber of
the eye or they can transgress the orbital septum and invade
the soft tissues of the orbit adjacent to the globe.[29,85] A rare
variant of squamous cell carcinoma of the conjunctiva is the
mucoepidermoid carcinoma. Clinically, this variant occurs
in older patients and has a yellow globular cystic component
due to the presence of abundant mucous‑secreting cells
within cysts. It tends to be more aggressive than the standard
squamous cell carcinoma and, therefore, deserves wider
excision and closer follow‑up.[2,25] The spindle cell variant of
squamous cell carcinoma is likewise aggressive.[7]

Conjunctival intraepithelial neoplasia (CIN)
Clinically, CIN appears as a fleshy, sessile or minimally elevated
lesion usually at limbus in the interpalprebal fissure and less
commonly in the forniceal or palpebral conjunctiva (Fig. 9).
The limbal lesion may extend for a variable distance into the
epithelium of the adjacent cornea. A white plaque (leukoplakia)
may occur on the surface of the lesion due to secondary
hyperkeratosis.

Figure 8: Epibulbar inclusion cyst with thick mucous from conjunctival
glands

a

b

Histopathologically, invasive squamous cell carcinoma is
characterized by malignant squamous cells that have violated

Figure 9: Conjunctival intraepithelial neoplasia (CIN; carcinoma‑in‑situ)
with corneal involvement, displaying leukoplakia on both the conjunctiva
and cornea

c

Figure 10: Invasive squamous cell carcinoma of the conjunctiva. (a) Gelatinous limbal squamous cell carcinoma. (b) Nodular squamous cell
carcinoma. (c) Flat diffuse squamous cell carcinoma of the cornea

[Downloaded free from http://www.ijo.in on Friday, December 13, 2019, IP: 147.140.233.15]

1938

Indian Journal of Ophthalmology

the basement membrane and have grown in sheets or cords into
the stromal tissue. As mentioned above, the mucoepidermoid
variant contains mucous‑secreting cells that often produce
mucous‑containing cysts within the lesion. Even though the
cells of invasive squamous cell carcinoma gain access to the
blood vessels and lymphatic channels, regional and distant
metastases are both rather uncommon. Patients who are
medically immunosuppressed for organ transplantation or
those with human immunodeficiency virus are at particular
risk to develop conjunctival squamous cell carcinoma. In
these cases, the risk for life‑ threatening metastatic disease is
greater.[51]
The management of squamous cell carcinoma of the
conjunctiva varies with the extent of the lesion. In general,
the management of lesions in the limbal area involves
alcohol epitheliectomy for the corneal component and partial
lamellar scleroconjunctivectomy with wide margins for the
conjunctival component followed by freeze‑thaw cryotherapy
to the remaining adjacent bulbar conjunctiva, similar to the
method used for limbal conjunctival melanoma.[78-80] In some
cases, microscopically controlled excision (Mohs surgery)
is performed at the time of surgery to ensure tumor‑free
margins.[3] Those tumors in the forniceal region can be managed
by wide local resection and cryotherapy. In cases where
excessive conjunctiva is sacrificed, a mucous membrane graft or
amniotic membrane graft may be employed for reconstruction.
In all cases, the full conjunctival component along with the
underlying Tenon›s fascia should be excised using the no
touch technique as mentioned previously. A thin lamella
of underlying sclera should be removed with the tumor for
those in the limbal region where the tumor is adherent to the
globe. The surgical management of conjunctival squamous
cell carcinoma is similar to the management of conjunctival
melanoma and is discussed further in the subsequent section
on melanoma.
For those patients with extensive tumors or those tumors
that are recurrent, especially those with extensive corneal
component, treatment with topical mitomycin C, 5‑fluorouracil,
or interferon is advised. [19,20,32,38,56,96,97] We generally use
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mitomycin C for two cycles with close monitoring of the
patient [Table 1].[56]

Melanocytic Tumors
There are several lesions that arise from the melanocytes of the
conjunctiva and episclera [Table 2]. The most important ones
include nevus, racial melanosis, primary acquired melanosis,
and malignant melanoma. Ocular melanocytosis should be
included in this discussion as its scleral pigmentation can
masquerade as conjunctival pigmentation.
Nevus
The circumscribed nevus is the most common melanocytic
tumor of the conjunctiva. It generally becomes clinically
apparent in the first or second decade of life as a discrete
variably pigmented, slightly elevated, sessile lesion that usually
contains fine clear cysts on slit‑lamp biomicroscopy (Fig. 11).[21,54]
It is typically located in the interpalpebral bulbar conjunctiva
near the limbus and remains relatively stationary throughout
life with less than 1% risk for transformation into malignant
melanoma.[21,54] The interpalpebral location is so classic that one
should doubt the diagnosis of nevus if a patient presents with
a forniceal or palpebral pigment mass and suspect primary
acquired melanosis, racial melanosis, or malignant melanoma.
Over time, a nevus can become more pigmented and the
previously inapparent nonpigmented portions can acquire
pigment, simulating growth.
Histopathologically, a conjunctival nevus is composed
of nests of benign melanocytes in the stroma near the basal
layers of the epithelium.[9] Like cutaneous nevus, it can be
junctional, compound, or deep. The best management is
usually periodic observation with photographic comparison
and if growth is documented then local excision of the lesion
should be considered. In some cases, excision for cosmetic
reasons is desired. At the time of excision, the entire mass is
removed using the no touch technique and, if it is adherent
to the globe, then a thin lamella of underlying sclera is
remove intact with the tumor.[78] Standard double freeze‑thaw
cryotherapy is applied to the remaining conjunctival margins.

Table 2: Differential Diagnosis of Pigmented Epibulbar Lesions
Condition

Anatomical
Location

Color

Depth

Margins

Laterality

Other Features

Progression

Nevus

Interpalpebral
limbus usually

Brown
or yellow

Stroma

Well
defined

Unilateral

Cysts

<1% progress to
conjunctival melanoma

Racial
melanosis

Limbus bulbar
palpebral
conjunctiva

Brown

Epithelium

Ill defined

Bilateral

Flat, no cysts

Very rare progression to
conjunctival melanoma

Ocular
melanocytosis

Bulbar
conjunctiva

Gray

Episclera

Ill defined

Unilateral
moreso than
bilateral

Congenital, usually
2 mm from limbus,
often with periocular
skin pigmentation

<1% progress to uveal
melanoma

Primary
acquired
melanosis
(PAM)
Malignant
melanoma

Anywhere, but
usually bulbar
conjunctiva

Brown

Epithelium

Ill defined

Unilateral

Flat, no cysts

Anywhere

Brown
or pink

Stroma

Well
defined

Unilateral

Vascular nodule, dilated
feeder vessels, may be
non‑pigmented

Progresses to
conjunctival melanoma
in nearly 50% cases
that show cellular atypia
32% develop metastasis
by 15 years

See Figure 11, Figure 12, Figure 13, Figure 14, Figure 15 for clinical illustrations
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These precautions are employed to prevent recurrence of the
nevus and also to prevent recurrence should the lesion prove
to be a melanoma.
Racial melanosis
Racial melanosis is a relatively common, bilateral condition
of flat conjunctival pigmentation found in darkly pigmented
individuals. This pigment is generally present at the limbus,
often for 360°, and a variable amount of this pigment can be
noted on the limbal cornea and bulbar conjunctiva (Fig. 12).
Uncommonly, this pigment involves the fornix and rarely the
palpebral conjunctiva. This pigmentation can occasionally
be mottled with a patchy appearance. It is extremely rare
for conjunctival melanoma to arise from racial melanosis.
Histopathologically, the pigmented cells are benign melanocytes
located in the basal layer of the epithelium. The recommended
management is periodic observation.
Ocular melanocytosis
Ocular melanocytosis is a congenital pigmentary condition
of the periocular skin, sclera, orbit, meninges, and soft palate.
Typically, there is no conjunctival pigment. However, this
condition is commononly confused with primary acquired
melanosis because of their similar appearance. In ocular
melanocytosis, flat, gray‑brown pigment scattered posterior to
the limbus on the sclera is visualized through the thin overlying
conjunctival tissue (Fig. 13). The entire uvea is also generally
affected by similar increased pigment. This condition imparts
a 1 in 400 risk for the development of uveal melanoma and not
conjunctival melanoma.[87] Affected patients should be followed
once or twice yearly for the development of uveal, orbital, or
meningeal melanoma.

a
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Primary acquired melanosis (PAM)
Primary acquired melanosis is an important benign conjunctival
pigmented condition that can give rise to conjunctival
melanoma. In contrast to conjunctival nevus, it is acquired in
middle age and appears diffuse, patchy, flat, and noncystic
[Fig. 14]. In contrast to ocular melanocytosis, the pigment is
acquired, located within the conjunctiva, and appears brown,
not gray, in color. The pigmentation can wax and wane over
time.[17,18,53] In contrast to racial melanosis, PAM generally
is found in fair‑skinned individuals as a unilateral patchy
condition.[22]
Histopathologically, PAM is characterized by the presence
of abnormal melanocytes near the basal layer of the epithelium.
Pathologists should attempt to classify the melanocytes as
having atypia or no atypia based on nuclear features and
growth pattern.[17,18] PAM with atypia carries nearly 50% risk
for ultimate evolution into malignant melanoma whereas
PAM without atypia carries nearly 0% risk for melanoma
development [Table 3].[17,18]
The management of PAM depends on the extent of
involvement and the association with melanoma. If there is
only a small region of PAM, occupying less than three clock
hours of the conjunctiva, then periodic observation or complete

b

Figure 11: Conjunctival nevus. (a) Pigmented conjunctival nevus.
(b) Nonpigmented conjunctival nevus

Figure 12: Racial melanosis found bilaterally in patient with dark skin
complexion

Figure 13: Ocular melanocytosis with episcleral gray pigment, heavy
uveal pigment, and little conjunctival pigment

Figure 14: Primary acquired melanosis of the conjunctiva, showing
the characteristic irregular patchy flat pigmentation
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excisional biopsy and cryotherapy are options.[78] If the PAM
occupies more than three clock hours, then incisional map
biopsy of all four quadrants is warranted, followed by double
freeze‑thaw cryotherapy to all affected pigmented sites. If
the patient has a history of previous or current conjunctival
or cutaneous melanoma or if there are areas of nodularity or
vascularity within the presumed PAM that are suspicious for
melanoma, then a more aggressive approach is warranted with
complete excisional biopsy of the suspicious areas using the
no touch technique as described previously. Additional small
incisional map biopsies should be performed in the regions of
flat PAM and even in the apparently uninvolved quadrants of
the bulbar conjunctiva to determine if there are melanocytes
with atypia. Cryotherapy should be applied to all remaining
pigmented areas. We manage patients who have PAM
associated with melanoma more aggressively than those with
PAM alone. If there is recurrent PAM on follow‑up, prompt
excisional biopsy and cryotherapy in the operating room or in
the outpatient clinic setting is provided. Topical mitomycin C
can also be beneficial, especially if there is recurrent corneal
PAM; however, mitomycin C is not as effective for PAM as it
is for squamous epithelial neoplasia.
Malignant melanoma
Malignant melanoma of the conjunctiva most commonly arises
from PAM, but it can also arise from a pre‑existing nevus or
de novo.[50,64] It typically arises in adults at a median age of
62 years, but rare cases of conjunctival melanoma in children
have been recognized.[64,91] Conjunctival melanoma shows
considerable clinical variability. It is generally a pigmented
or tan, elevated conjunctival lesion that can be located on the
limbal, bulbar, forniceal, or palpebral conjunctiva (Fig. 15).
Occasionally, the tumor shows predominance on the cornea,
despite origin from the conjunctiva.[93] Often prominent feeder
vessels and surrounding flat PAM are present. Conjunctival
melanoma can show both local tumor recurrence and distant
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metastasis (Tables 4-6).[40,41,50,64] Multiple recurrences, especially
those that occur within the orbit, frequently necessitate orbital
exenteration.[40,64,84] Metastases to ipsilateral facial lymph
nodes, brain, lung, and liver are the most common sites.[15,64]
Histopathologically, conjunctival melanoma is composed
of variably pigmented malignant melanocytes within the
conjunctival stroma. There may be microscopic evidence of
PAM or a nevus.
The management of conjunctival melanoma varies with the
extent of the lesion.[52] This malignancy is particularly difficult
to treat. Despite excellent microscopic excision of the mass,
further disease can develop from associated PAM in 26% of
patients by 5 years and 65% of patients by 15 years follow‑up
[Table 4].[64] Classic limbal tumors are removed by absolute
alcohol epitheliectomy for the flat corneal component and wide
no touch technique, partial lamellar scleroconjunctivectomy with
4 mm margins followed by double freeze‑thaw cryotherapy
for the conjunctival portion. Larger lesions that extend into the
forniceal region or orbit may require more extensive excision,
always with tumor free margins encapsulating the tumor and
with no touch, dry technique (Fig. 1). Closure is achieved by
primary apposition of conjunctiva or with conjunctival rotational
flaps, mucous membrane graft from the opposite eye or buccal
mucosa, or amniotic membrane transplantation.[60] Often, fornix
deepening sutures or a symblepharon ring is required to reform
the fornix. Lesions that extend into the globe may require a
modified enucleation and those that extend into the orbit may
require orbital exenteration as described above.[18,64,81,84] Paridaens
and associates found that early exenteration did not improve life
prognosis.[40] Shields and associates found tumor related death
occurred in 7% of patients at 5 years and 13% at 8 years.[64] The
risk factors for death using multivariate analysis included initial
symptoms (lump) (p = 0.004) and pathology findings (de novo
melanoma without primary acquired melanosis) (p = 0.05). The
technique of initial surgery (using complete excisional biopsy

Table 3: Histopathologic Classification of Primary Acquired Melanosis of the Conjunctiva and Risks for Evolution into
Conjunctival Melanoma
General Classification

Risk for Development of Conjunctival Melanoma

Primary acquired melanosis without atypia

0%

Primary acquired melanosis with atypia

46%

If atypical melanocytes in the epithelium located in other than the basal layer of
the epithelium
If atypical melanocytes showing epithelioid cellular features (abundant cytoplasm)

90%
75%

From Folberg et al.17 x17. Folberg, R., McLean, I.W., and Zimmerman, L.E. Primary acquired melanosis of the conjunctiva. Hum Pathol. 1985; 16: 136‑143

a

b

c

Figure 15: Conjunctival melanoma. (a) Pigmented melanoma that arose de novo. (b) Pigmented melanoma that arose from primary acquired
melanosis (left arrow). Note the flat extension of the melanoma into the cornea. (c) Nonpigmented melanoma, recurrent following previous excisions

[Downloaded free from http://www.ijo.in on Friday, December 13, 2019, IP: 147.140.233.15]
Shields and Shields: Conjunctival corneal tumors

December 2019

with the no touch technique combined with cryotherapy to
remaining tumor free margins) was shown to be an important
factor in preventing eventual tumor recurrence (p = 0.07),
metastasis (p = 0.03), and death (p = 0.006) in the univariate
analysis, but did not reach significance in the multivariate
analysis.[64]
Conditions that can simulate conjunctival melanocytic
tumors
There are several benign, non‑neoplastic conditions that can
resemble conjunctival PAM or melanoma and these include
pingueculum, pterygium, Axenfeld’s nerve loops at the
site of a scleral emissarial canal, mascara deposition in the
inferior fornix, silver deposition on the entire conjunctival
surface in patients who have used argyrol eyedrops,
gunpowder deposition in patients exposed to gunpowder
explosions, adrenochrome pigment in the inferior fornix
in patients using epinephrine eyedrops, hemorrhagic
conjunctival cyst following previous surgery, pigmented
cells trapped within a non‑melanocytic tumor (fellow
travelers),[83] ochronosis pigmentation at the site of muscle
insertion and in pingueculum in patients with alkaptonuria,
and calcified Cogan›s scleral plaque at the horizontal rectus
Table 4: Risks for Local Tumor Recurrence, Exenteration,
Metastasis, and Death in Patients with Conjunctival
Melanoma
Outcome

Length of follow‑upa
±5 years

±10 years

±15 years

Recurrence (%)

26

51

65

Exenteration (%)

8

16

32

Metastasis (%)
Death (%)

16
7

26
13

32
na

Kaplan Meier life table analysis. na=not available. From Shields et al.64 x 64.
Shields, C.L., Shields, J.A., Gunduz, K. et al. Conjunctival melanoma: risk
factors for recurrence, exenteration, metastasis, and death in 150 consecutive
patients. Arch Ophthalmol. 2000; 118: 1497‑1507
a

Table 5: Clinical Factors Predictive of Local Tumor
Recurrence Following Resection of Conjunctival Melanoma
Factor
Tumor location extralimbal
Tumor extending to surgical
margin (histopathologically)

P

Relative Risk

0.01
0.02

2.3
2.9

muscle insertions in older adults. [76] Understanding and
recognition of these pseudomelanomas should be achieved by
clinicians managing patients with conjunctival malignancies.

Vascular Tumors
Pyogenic granuloma
Pyogenic granuloma is a proliferative fibrovascular response
to prior tissue insult by inflammation, surgery, or nonsurgical
trauma. It is sometimes classified as a polypoid form of acquired
capillary hemangioma.[16] It appears clinically as an elevated red
mass, often with a florid blood supply. Microscopically, it is
composed of granulation tissue with chronic inflammatory cells
and numerous small caliber blood vessels (Fig. 16). Because the
lesion is rarely pyogenic nor granulomatous, the term “pyogenic
granuloma” may be a misnomer. Pyogenic granuloma will
sometimes respond to topical corticosteroids but many cases
ultimately require surgical excision. In bothersome recurrent
cases, low‑dose plaque radiotherapy can be applied.[26]
Capillary hemangioma
Capillary hemangioma of the conjunctiva generally presents
in infancy, several weeks following birth, as a red stromal
mass, sometimes associated with cutaneous or orbital capillary
hemangioma (Fig. 17). Similar to its cutaneous counterpart, the
conjunctival mass might enlarge over several months and then
spontaneously involute. Management includes observation
most commonly, but surgical resection or local or systemic
prednisone can be employed.
Cavernous hemangioma
Cavernous hemangioma of the conjunctiva is rare.[94] This
benign tumor appears as a red or blue lesion usually in the
deep stroma in young children (Fig. 18). It may be similar to
the orbital cavernous hemangioma that is generally diagnosed
in young adults. It can be managed by local resection.
Racemose hemangioma
Occasionally, dilated arteriovenous communication without
intervening capillary bed (racemose hemangioma) is found
in the conjunctiva. This appears as a loop or neatly wound
monolayer of a dilated, noncrossing vessel in the stroma
with no evident stimulus or planned direction. It can remain
stable for years and is generally monitored conservatively. It is
important to rule out Wyburn–Mason syndrome in these cases.

From Shields et al.64 x 64. Shields, C.L., Shields, J.A., Gunduz, K. et al.
Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis,
and death in 150 consecutive patients. Arch Ophthalmol. 2000; 118: 1497‑1507

Table 6: Clinical Factors Predictive of Tumor Metastasis
from Conjunctival Melanoma
Factor
Tumor extending to surgical
margin (histopathologically)
Tumor location extralimbal

P

Relative Risk

0.005

5.7

0.03

3.1

From Shields et al.64 x 64. Shields, C.L., Shields, J.A., Gunduz, K. et al.
Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis,
and death in 150 consecutive patients. Arch Ophthalmol. 2000; 118: 1497‑1507

1941

Figure 16: Pyogenic granuloma
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Lymphangioma
Conjunctival lymphangioma can occur as an isolated
conjunctival lesion or, more often, it represents a superficial
component of a deeper diffuse orbital lymphangioma.[95] It
usually becomes clinically apparent in the first decade
of life and appears as a multliloculated mass containing
variable‑sized clear dilated cystic channels (Fig. 19). In
most instances, one sees blood in many of the cystic spaces.
These have been called “chocolate cysts.” The treatment
of conjunctival lymphangioma is often extremely difficult
because surgical resection or radiotherapy cannot completely
eradicate the mass.
Varix
Varix is a venous malformation that can be found in the orbit
and rarely the conjunctiva. It is a mass of dilated venous
channels that can enlarge with Valsalva maneuver. Some
authorities believe that this condition is in the spectrum of
lymphangioma. Treatment involves cautious observation. If
clotted and painful, cold compresses and aspirin may be useful.
Surgical resection should be cautiously employed due to the
risk for prolonged bleeding at surgery.[71]
Hemangiopericytoma
Hemangiopericytoma is a tumor composed of the pericytes
that surround blood vessels.[24] It can show both benign and
malignant cytological features. It appears as a red conjunctival

Figure 17: Capillary hemangioma of the conjunctiva in a newborn infant

Figure 19: Lymphangioma of the conjunctiva
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mass originating from the stroma. Wide surgical resection with
tumor‑free margins is advised.
Kaposi’s sarcoma
Kaposi’s sarcoma is best known as a cutaneous malignancy
that occurs in elderly immunosuppressed patients. With the
advent of acquired immune deficiency syndrome (AIDS), this
tumor has become more common and often affects mucous
membranes, including conjunctiva. Clinically, it appears as
one or more reddish vascular masses that may resemble a
hemorrhagic conjunctivitis (Fig. 20). It is moderately responsive
to chemotherapy and markedly responsive to low dose
radiotherapy.[69]

Fibrous Tumors
Fibroma
Fibroma is a rare conjunctival tumor that appears as a white stromal
mass, either unifocal or multifocal.[31] Surgical resection is advised.
Fibrous histiocytoma
Fibrous histiocytoma is a rare mass of the conjunctiva and
is comprised of fibroblasts and histiocytes. Clinically and
histopathologically it resembles many other amelanotic stromal
tumors. In the conjunctiva it can be benign, locally invasive, or
malignant. Wide excision with tumor‑free margins is advised.

Figure 18: Cavernous hemangioma of the conjunctiva in a young child

Figure 20: Kaposi’s sarcoma of the conjunctiva with typical surrounding
hemorrhage
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Nodular fasciitis
Nodular fasciitis is a benign proliferation of connective
tissue that most commonly occurs in the skin and less
commonly in the eyelid, orbit, and conjunctiva. Clinically and
histopathologically it can resemble fibrosarcoma. The lesion
appears as a solitary white mass in Tenon’s fascia. Complete
excision is advised as the lesion can recur.

Neural Tumors
Neural tumors of the conjunctiva are rare. They tend to manifest
a more yellow appearance than the fibrous tumors.
Neurofibroma
Neurofibroma can occur in the conjunctiva as a solitary mass
or as a diffuse or plexiform variety. The former is not usually
associated with systemic conditions and the latter is generally
a part of von Recklinghausen’s neurofibromatosis.[58,75] The
solitary tumor is a slowly enlarging elevated stromal mass that
is best managed by complete surgical resection. The plexiform
type is more difficult to surgically excise and debulking
procedures are often necessary.
Neurilemoma
Neurilemoma, also known as schwannoma, is a benign
proliferation of Schwann cells that surround the peripheral
nerves. This tumor more commonly arises in the orbit, but there
are reports of similar rare tumor in the conjunctiva.[44] Clinically,
this lesion is a yellowish‑pink, nodular mass in the stroma.
Complete excision is warranted to minimize recurrence.
Granular cell tumor
Granular cell tumor is a rare tumor and of disputed origin,
but currently, most authorities speculate that it is of Schwann
cell origin.[76] This benign tumor clinically appears smooth,
vascular, and pink, and is located in the stroma or within
Tenon›s fascia. Histopathologically, it is comprised of large
round cells with pronounced granularity to the cytoplasm.
Complete excision is advised.

Histiocytic Tumors
Xanthoma
Xanthoma most often occurs within the cutaneous dermis,
near extensor surfaces and its location on the conjunctiva
is exceptionally rare. Conjunctival xanthoma appears as
a yellow subepithelial smooth mass affecting one or both
epibulbar surfaces. Bilateral conjunctival involvement has
been found in a condition termed xanthoma disseminatum.
Histopathologically, subepithelial infiltrate of lipidized
histiocytes, eosinophils, and Touton giant cells are seen.
Juvenile xanthogranuloma
Juvenile xanthogranuloma is a relatively common cutaneous
condition that presents as painless, pink skin papules with
spontanteous resolution, generally in children under the
age of 2 years. Rarely, conjunctival, orbital, and intraocular
involvement is noted. In the conjunctiva, the mass appears as an
orange‑pink stromal mass, typically in young adults (Fig. 21).
If the classic skin lesions are noted, the diagnosis is established
clinically and treatment with observation or topical steroid
ointment is provided. Otherwise, biopsy is suggested and
recognition of the typical histopathologic features of histiocytes
admixed with Touton’s giant cells confirms the diagnosis.

1943

Reticulohistiocytoma
Reticulohistiocytoma is a rare tumor, often found as part of
a systemic multicentric reticulohistiocytosis. Clinically, the
tumor appears as a pink, vascular limbal mass in an adult.
Histopathologically, it is comprised of large histiocytes with
granular cytoplasm.[13]

Myxoid Tumors
Myxoma
Myxoma is a rare conjunctival tumor that appears as an
orange‑pink mass within the stroma. The tumors are slow
growing, freely movable solitary lesions located usually in
the temporal bulbar conjunctiva. Histologically, they are
hypocellular and were composed of stellate and spindle‑shaped
cells interspersed in a loose stroma.[43,68,77]

Myogenic Tumors
Rhabdomyosarcoma
Ophthalmic rhabdomyosarcoma is generally regarded as a
primary orbital tumor; however, it can occur primarily in
the conjunctiva and even within the globe.[66] Conjunctival
rhabdomyosarcoma appears as a pink, vascular mass with
rapid growth, usually over 1 to 2 months. Complete excisional
biopsy is advised and adjunctive therapy with chemotherapy
and possibly radiotherapy is warranted depending on many
factors.[66]

Lipomatous Tumors
Lipoma
Conjunctival lipoma is quite rare and generally is found in
adults as a yellowish‑pink stromal mass.[68,77] They are generally
of pleomorphic type with large lipid vacuoles surrounded by
stellate cells.
Herniated orbital fat
Occasionally, orbital fat presents in the conjunctiva as a herniation
from the superotemporal orbit. The condition is often bilateral
and represents deficiency in the orbital connective tissue to
maintain the proper location of the normal orbital fat. Clinically,
the mass is deep to Tenon’s fascia and is most prominent on
inferonasal gaze (Fig. 22). Digital reposition of the fat into the
orbit can be performed, but is only temporary. Management

Figure 21: Juvenile xanthogranuloma of the conjunctiva in a child
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is observation, unless the condition causes symptoms of dry
eye from eyelid malposition. In these cases, resection of the
herniated fat and resuspension of the orbit position of the fat is
advised. Histopathologically, the tissue comprises large lipid
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cells. Daniel and coauthors recently described six patients with
typical herniated orbital fat that proved on histopathology to
have pleomorphic lipoma, with large pleomorphic cells within
the adipose tissue arranged in a floret‑like pattern.[12] They noted
the clinical overlap between these two conditions.
Liposarcoma
Liposarcoma of the conjunctiva has been rarely recognized and
shows clinical features similar to lipoma. Histopathologically,
neoplastic stellate lipid cells and signet‑ring type cells have
been observed.[77]

Lymphoid Tumors

Figure 22: Herniated orbital fat

a

b

Figure 23: Conjunctival lymphoma. (a) Limbal tumor. (b) Forniceal tumor

Lymphoid tumors can occur in the conjunctiva as isolated lesions
or they can be a manifestation of systemic lymphoma.[6,8,34,37,61]
Clinically, the lesion appears as a diffuse, slightly elevated
pink mass located in the stroma or deep to Tenon›s fascia, most
commonly in the forniceal region (Fig. 23). This appearance is
similar to that of smoked salmon; hence it is termed the “salmon
patch.”[61] It is not usually possible to differentiate clinically
between a benign and malignant lymphoid tumor. Therefore,
biopsy is necessary to establish the diagnosis and a systemic
evaluation should be done in all affected patients to exclude the
presence of systemic lymphoma [Table 7]. Histopathologically,
sheets of lymphocytes are found and classified as reactive
lymphoid hyperplasia or malignant lymphoma. Most are B cell
lymphoma (non‑Hodgkin›s type). Rarely, T cell lymphoma is
noted.[62] Treatment of the conjunctival lesion should include
chemotherapy if the patient has systemic lymphoma or external
beam irradiation (2,000–4,000 cGy) if the lesion is localized to
the conjunctiva. Other options include excisional biopsy and
cryotherapy,[14] local interferon injections, or observation.

Leukemia
Leukemia generally manifests in the ocular region as
hemorrhages from associated anemia and thrombocytopenia
rather than leukemic infiltration. [46] However, leukemic
infiltration can be found with chronic lymphocytic leukemia.
In these cases, the tumor appears as a pink smooth mass
within the conjunctival stroma either at the limbus or the
fornix, similar to a lymphoid tumor. Biopsy reveals sheets
of large leukemic cells. Treatment of the systemic condition
is advised with secondary resolution of the conjunctival
infiltration.

Metastatic Tumors
Figure 24: Metastatic breast carcinoma to the conjunctiva

a

b

Metastatic tumors rarely occur in the conjunctiva but
conjunctival metastasis can occur from breast carcinoma,

c

Figure 25: Caruncular tumors. (a) Papilloma of the caruncle. (b) Nevus of the caruncle. (c) Oncocytoma of the caruncle
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cutaneous melanoma, and other primary tumors.[33] Metastatic
carcinoma appears as one or more fleshy pink vascularized
conjunctival stromal tumors (Fig. 24). Metastatic melanoma
to the conjunctiva usually is pigmented.[33]

Secondary Conjunctival Involvement from
Adjacent Tumors
The conjunctiva can be secondarily involved by tumors of
adjacent structures, particularly by direct extension from
tumors of the eyelids. The most important tumor to exhibit this
behavior is sebaceous gland carcinoma of the eyelid.[5,28] This
tumor can exhibit pagetoid invasion and extend directly into
the conjunctival epithelium. This can result in a clinical picture
compatible with chronic unilateral blepharoconjunctivitis. Uveal
melanoma in the ciliary body region can extend extrasclerally into
the subconjunctival tissues, simulating a primary conjunctival
tumor. Rhabdomyosarcoma of the orbit, a tumor typically found
in children, occasionally presents first with its conjunctival
component before the mass is discovered in the orbit.[66,73]

Caruncular Tumors and Cysts

Method of Literature Search
A comprehensive literature search over the past 30 years
was derived from PubMed using general search words
conjunctiva, cornea, caruncle, tumor, neoplasia, cancer, and
malignancy. Additional search words were input for each
of the 47 specific diagnostic entities listed in the outline
from dermoid to liposarcoma to caruncle tumor. The search
words conjunctiva tumor yielded 77 pages of 1,536 references.
The search words conjunctiva neoplasia yielded 74 pages of
1,473 references, conjunctiva melanoma yielded 19 pages of
364 references, and conjunctiva squamous cell carcinoma produced
13 pages of 249 references. Additional references were gathered
from published articles that provided a literature review of
a topic. References used in this report included those that
represented the first or second report in the literature of
an entity or treatment of an entity, those that represented
substantial case series of certain entities, and those that were
Table 8: Types and Frequency of Tumors of the Caruncle:
Comparison of Two Major Survey

The caruncle is a unique anatomic structure that contains elements
of both conjunctiva and skin. The tumors and related lesions
that develop in the caruncle are similar to those that occur in
mucous membranes and cutaneous structures. By histopathologic
analysis, 95% of caruncular tumors are benign and 5% are
malignant.[35] The most common lesions include papilloma and
nevus [Table 8] (Fig. 25).[35,67] Other caruncular lesions include
pyogenic granuloma, inclusion cyst, sebaceous hyperplasia, and
sebaceous adenoma, and oncocytoma.[59] Malignant tumors such
as squamous cell carcinoma, melanoma, lymphoma, and sebaceous
carcinoma are relatively rare in the caruncle. The oncocytoma is a
benign tumor that occurs more commonly in the lacrimal or salivary
glands. In the caruncle it probably arises from accessory lacrimal
gland tissue and often has a blue cystic appearance (Fig. 25). The
treatment of most caruncular masses is either observation or local
resection, depending on the final diagnosis.

Lesions (%)

Luthra et al.35
(n=112)

Shields
et al.67 (n=57)

Papilloma

13

32

Nevus

43

24

Pyogenic granuloma

3

9

Epithelial inclusion cyst

4

7

Chronic inflammation

4

7

Oncocytoma

4

4

Normal caruncle

0

4

Sebaceous gland hyperplasia

8

2

Sebaceous gland adenoma

0

2

Lipogranuloma

0

2

Seborrheic keratosis

1

2

Lymphangiectasia

0

2

Miscellaneous Lesions that can Simulate
Conjunctival Neoplasms

Histiocytic lymphoma

0

2

Squamous cell carcinoma

0

2

Basal cell carcinoma

0

2

A number of non‑neoplastic conditions can simulate
neoplasms. These include pingueculum, pterygium, foreign
body, inflammatory granuloma, amyloidosis, and others.[76] In
most instance, the history and clinical findings should make
the diagnosis obvious. In some instances, however, excision
of the mass may be necessary in order to exclude a neoplasm.

Reactive lymphoid hyperplasia

4

0

Foreign body granuloma

3

0

Malignant melanoma

2

0

Capillary hemangioma

2

0

Senile keratosis

1

0

Freckle

1

0

Adrenochrome pigment

1

0

Cavernous hemangioma

1

0

Dermoid

1

0

Granular‑cell myeloblastoma

1

0

Plasmacytoma

1

0

Apocrine hydrocystoma

1

0

Table 7: Risks for the Development of Systemic
Lymphoma in Patients who Present with Conjunctival
Lymphoid Infiltrate and No Sign of Systemic Lymphoma
Development of Systemic Lymphoma

Generally, if conjunctival
lymphoid tumor (%)
Specifically, if conjunctival
lymphoma (%)

±1 years

±5 years

±10 years

7

15

28

Pilar cyst

1

0

79

Sebaceous gland carcinoma
Ectopic lacrimal gland

1
1

0
0

12

38

From Shields et al.61 x 61. Shields, C.L., Shields, J.A., Carvalho, C. et al.
Conjunctival lymphoid tumors: clinical analysis of 117 cases and relationship
to systemic lymphoma. Ophthalmology. 2001; 108: 979‑984

From Luthra, C.L., Doxanas, M.T., and Green, W.R. Lesions of the caruncle.
A clinicopathologic study. Surv Ophthalmol. 1978; 23: 183‑195 and Shields,
C.L., Shields, J.A., White, D., and Augsburger, J.J. Types and frequency of
lesions of the caruncle. Am J Ophthalmol. 1986; 102: 771‑778
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particularly well‑written, well‑illustrated, or recent publication.
English literature articles were used and non‑English articles
were included if they met the above criteria.
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